Highbridge Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,656
| Closed | -$1.6M | – | 763 |
|
|
2017
Q3 | $1.6M | Buy |
+13,656
| New | +$1.6M | 0.02% | 373 |
|
|
2016
Q4 | – | Sell |
-6,447
| Closed | -$437K | – | 974 |
|
|
2016
Q3 | $437K | Buy |
+6,447
| New | +$437K | 0.01% | 713 |
|
|
2016
Q2 | – | Sell |
-89,786
| Closed | -$5.64M | – | 1034 |
|
|
2016
Q1 | $5.64M | Buy |
+89,786
| New | +$5.64M | 0.09% | 201 |
|
|
2015
Q3 | – | Sell |
-29,500
| Closed | -$3.54M | – | 879 |
|
|
2015
Q2 | $3.54M | Sell |
29,500
-905
| -3% | -$108K | 0.04% | 311 |
|
|
2015
Q1 | $3.18M | Buy |
+30,405
| New | +$3.18M | 0.04% | 343 |
|
|
2014
Q2 | – | Sell |
-5,240
| Closed | -$352K | – | 712 |
|
|
2014
Q1 | $352K | Buy |
5,240
+700
| +15% | +$47K | ﹤0.01% | 563 |
|
|
2013
Q4 | $292K | Buy |
+4,540
| New | +$292K | ﹤0.01% | 572 |
|
|
2013
Q3 | – | Sell |
-6,718
| Closed | -$209K | – | 891 |
|
|
2013
Q2 | $209K | Buy |
+6,718
| New | +$209K | ﹤0.01% | 833 |
|